BioSpace News Archive

Brain Scientific Inc., a medical device and technology company offering products and solutions related to the brain including neurology, AI and machine learning, has enhanced its disposable EEG headset, NeuroCapTM, with new features.

Myriad Genetics, Inc., a global leader in molecular diagnostics and precision medicine, announced the election of Daniel K. Spiegelman, age 61, to its Board of Directors, effective immediately, expanding the Board to nine members.

RedHill Biopharma Ltd. (Nasdaq: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that Mr. Dror Ben-Asher, RedHill’s Chief Executive Officer, will present a corporate overview at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 11:00 a.m. EDT . The presentation will be broadcast live and available via replay for 30 days on the Company’s website, htt

Cerecor Inc. announced that it has received clearance from the U.S. Food and Drug Administration to proceed with a proof-of-concept clinical trial of its anti-LIGHT monoclonal antibody CERC-002 in patients with COVID-19 cytokine storm induced Acute Respiratory Distress Syndrome. The study will assess the efficacy and safety of CERC-002.

Avanos Medical, Inc. announced that it would present at the following two virtual investor conferences in June

Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that management will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 8:30 am E.T.

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced it will host a conference call to review clinical updates and financial results for the three months ended March 31, 2020 on Monday, June 1, 2020 at 8:30 a.m. EDT.

RaySearch Laboratories AB and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare®* oncology information system to connect to Varian TrueBeam linear accelerators.

MacroGenics, Inc. announced that during the recent mid-cycle communication with the U.S. Food and Drug Administration, the FDA notified the Company that it is no longer planning to hold an Oncologic Drugs Advisory Committee meeting to discuss the Biologics License Application for margetuximab.

ReWalk Robotics Ltd. announced its financial results for the three months ended March 31, 2020.